Replies to post #41827 on Ayala Pharmaceuticals Inc (ADXS)

[trading_cyclist]

What do you think the BO price will be?

[BarrellofHay]

My understanding is phase iii data won’t be known till 2020. So what are other data results timeline? What we need is for them to start neo and get milestones. Has BMY dual started? This company has burned through 300 million dollars and has only reported on a handful of patients with little controls . Just insane amount of cash burning

[khaled_shatila]

I said it before and i will say it again. Posters at conferences mean NOTHING, i have been to many conferences in the past and the poster sessions are a hit or miss where some posters aren't even noticed. also the people at these conferences are usually looking at the poster from a medical standpoint. Just this September i went to a national medical conference and when i was at the poster session i remembered the people on this board group and took a picture of posters with no people around to show this board what a poster session really means (nothing). when i came back home i didn't know how to attach that figure on to a post at IHUB so i let it be. Even oral presentations won't move the stock. nothing short of late breaking phase 3 clinical trial (better if stopped early due to beneficial results) or a major deal or solid source of income, these are the stuff we are waiting for. last week i said i have a feeling this week we might have rise in PPS it wasn't because of the meeting, i was speculating that since they are in europe they can be having side talks with a european partner and we might hear about that this week, as this week is still not over i think i will wait till end of next week before dismissing any news coming out of this trip to europe.